The Board requests the Chair to assign to a committee of the Board the task of investigating the feasibility of an additional mechanism for providing special funding to allow rapid access to new technologies to diagnose, prevent or treat one of the three diseases. This could involve reprogramming or additional funding to existing grantees and /or an extraordinary funding round to allow countries without current grants access to new funding.
The committee should report back to the Board on the results of this review at the Seventeenth Board meeting. It can, at its discretion, include in that report a recommendation for a specific mechanism for Board consideration and possible approval.
The budgetary implications for this decision are $31,500 which includes an allocation for one short-term position in 2007.